DE689838T1 - Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen - Google Patents

Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen

Info

Publication number
DE689838T1
DE689838T1 DE0689838T DE95401504T DE689838T1 DE 689838 T1 DE689838 T1 DE 689838T1 DE 0689838 T DE0689838 T DE 0689838T DE 95401504 T DE95401504 T DE 95401504T DE 689838 T1 DE689838 T1 DE 689838T1
Authority
DE
Germany
Prior art keywords
diademosim
tetraphosphate
treatment
ischemic myocardial
myocardial diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0689838T
Other languages
English (en)
Inventor
Masafumi Kitakaze
Masatsugu Hori
Takenobu Kamata
Hiroshi Nakajima
Akihiro Sekine
Tetsuaki Yamaura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Unitika Ltd
Original Assignee
Fujirebio Inc
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc, Unitika Ltd filed Critical Fujirebio Inc
Publication of DE689838T1 publication Critical patent/DE689838T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE0689838T 1994-06-30 1995-06-23 Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen Pending DE689838T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6149971A JPH0812581A (ja) 1994-06-30 1994-06-30 虚血性心疾患治療剤

Publications (1)

Publication Number Publication Date
DE689838T1 true DE689838T1 (de) 1996-10-10

Family

ID=15486632

Family Applications (1)

Application Number Title Priority Date Filing Date
DE0689838T Pending DE689838T1 (de) 1994-06-30 1995-06-23 Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen

Country Status (5)

Country Link
US (1) US5571524A (de)
EP (1) EP0689838A1 (de)
JP (1) JPH0812581A (de)
KR (1) KR0149114B1 (de)
DE (1) DE689838T1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7348315B2 (en) 1995-03-23 2008-03-25 The University Of Connecticut Methods of treating heart failure with modified ATP, ADP and AMP compounds
GB9711848D0 (en) * 1997-06-06 1997-08-06 William Harvey Research Limite Treatment and prophylaxis of infraction
IT1308613B1 (it) 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
US7045152B2 (en) 1999-09-08 2006-05-16 Duke University Treating pulmonary disorders with gaseous agent causing repletion of GSNO
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62278992A (ja) 1986-05-28 1987-12-03 Unitika Ltd ジアデノシン四リン酸又はその誘導体の製造方法
WO1989004321A1 (en) * 1987-11-05 1989-05-18 The Worcester Foundation For Experimental Biology Diadenosine 5', 5'''-p1, p4-tetraphosphate and analogs thereof as antithrombotic agents
US5049550A (en) * 1987-11-05 1991-09-17 Worcester Foundation For Experimental Biology Diadenosine 5', 5'"-p1, p4,-tetraphosphate analogs as antithrombotic agents
JP2783880B2 (ja) 1989-11-24 1998-08-06 富士レビオ株式会社 心臓病治療剤
JPH05286861A (ja) * 1992-04-06 1993-11-02 Fujirebio Inc 低血圧維持剤
JP3080771B2 (ja) * 1992-04-17 2000-08-28 ユニチカ株式会社 ジヌクレオシドポリリン酸又はその誘導体の製造方法

Also Published As

Publication number Publication date
KR960000226A (ko) 1996-01-25
US5571524A (en) 1996-11-05
KR0149114B1 (ko) 1998-10-15
EP0689838A1 (de) 1996-01-03
JPH0812581A (ja) 1996-01-16

Similar Documents

Publication Publication Date Title
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE69109560T2 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE689838T1 (de) Verwendung von Diademosim 5',5'''-p1,p4-Tetraphosphat zur Behandlung von ischämischen Myokard-Erkrankungen
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69518438T2 (de) Behandlung von übereregten nervenzellenfunktionen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
NO982562D0 (no) Sammensetning for behandling av smerte
DE69408394T2 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
DE69806062T2 (de) Kombinationstherapie zur behandlung von aids
DE69314413D1 (de) Piperidino-3,4-dihydrocarbostyryl Verbindungen zur Behandlung von ischämischen Störungen